Mind the gap: Estimating the opportunity lost due to the gap between FDA and EMA cancer drug approvals.

被引：0
|
作者：
Gage, Samantha
Eteshola, Elias
Hadfield, Matthew James
Hamze, Dany
Khaki, Ali Raza
Mishra, Sanjay
Rooney, Michael Kevin
Masse, Gabrielle
Hilal, Talal
Jain, Sandeep Kumar
Rubinstein, Sam
Lythgoe, Mark
Warner, Jeremy Lyle
机构：
[1] Lifespan, Providence, RI USA
[2] Brown Univ, Providence, RI USA
[3] Brown Univ, Rhode Isl Hosp, Providence, RI USA
[4] Stanford Univ, Stanford, CA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Lifespan Canc Inst, Providence, RI USA
[7] Mayo Clin, Phoenix, AZ USA
[8] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[9] Imperial Coll London, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11030
引用
收藏
页数：1
相关论文
共 21 条
  • [1] Time intervals between US Food and Drug Administration (FDA) and European Medicines Agency (EMA) new cancer therapy approvals.
    Lythgoe, Mark
    Krell, Jonathan
    Warner, Jeremy Lyle
    Desai, Aakash
    Khaki, Ali Raza
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
    Stirland, Darren Lars
    Nichols, Joseph W.
    Miura, Seiji
    Bae, You Han
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (03) : 1045 - 1064
  • [3] Comparison of Drug Approvals in Europe Versus the United States: An Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA
    Makuch, Robert W.
    Shi, Ruizhi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (03) : 362 - 366
  • [4] Comparison of Drug Approvals in Europe Versus the United StatesAn Analysis of Discrepancies Between Drug Products Reviewed by EMA and FDA
    Robert W. Makuch
    Ruizhi Shi
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 362 - 366
  • [5] Antineoplastic drug approvals by European Medicines Agency (EMA) and Food and Drug Administration (FDA) between 2018-2021. Evaluation of potential differences
    Alcubilla, P.
    Arellano, L.
    Aparicio, L.
    Burunat, L.
    Sanchez, C.
    Saez-Penataro, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S19 - S19
  • [6] Lost in translation: bridging the gap between cancer research and effective therapies
    D Del Bufalo
    A Bagnato
    A Fusco
    M Milella
    Cell Death & Differentiation, 2011, 18 : 1082 - 1084
  • [7] Lost in translation: bridging the gap between cancer research and effective therapies
    Del Bufalo, D.
    Bagnato, A.
    Fusco, A.
    Milella, M.
    CELL DEATH AND DIFFERENTIATION, 2011, 18 (06): : 1082 - 1084
  • [8] Mind the cancer screening gap between medical rationale and laypersons' reasoning
    Hagoel, L.
    Feder-Bubis, P.
    JOURNAL OF INTERNAL MEDICINE, 2016, 279 (06) : 563 - 565
  • [9] Mind the Gap: Differences in Acute Myocardial Infarction Care Due to a Cancer Diagnosis in England
    Quintana, Raymundo A.
    Ghosh, Arjun K.
    Kondapalli, Lavanya
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (06): : 398 - 400
  • [10] Ethnic origin in cancer clinical trials: overrated or understated? A comprehensive analysis of cancer clinical trials leading to FDA and EMA approvals between 2020 and 2022
    Puhr, H. C.
    Winkler, E. C.
    Preusser, M.
    ESMO OPEN, 2025, 10 (01)
123